Post Doctoral Scientist-Immuno-Oncology and Myeloid Biology Research-Fixed Duration Employment

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our 39,000 employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We're looking for people who are determined to make life better for people around the world.

Responsibilities

For more than 130 years, Eli Lilly and Company has been dedicated to meeting the health care needs of people in the United States and around the world. We address these needs primarily by developing innovative medicines-investing a higher percentage of our sales in research and development than any other major pharmaceutical company. If you are interested in being considered for employment with a "Best in Class" Pharmaceutical company, please review the following opportunity:

The Oncology Research Division at Eli Lilly and Company has established a robust pipeline of innovative small molecule and biotherapeutic agents to address major unmet medical needs of cancer patients.

We reaffirmed our commitment to invest in R&D facilities across the United States. We're proud to have celebrated the opening of our Immuno-Oncology Research and Development Center of Excellence in New York City. Lilly completed an expansion of our site at the Alexandria Center for Life Science. The site houses a dynamic immuno-oncology R&D center of excellence (IOCE) focused on advancing the next generation of immunotherapies. The research facility represents Lilly's dedication to developing life-changing medicines, and to improving the care of people living with cancer.

As Lilly Oncology continues its mission to deliver lifesaving and tailored treatments to cancer patients and to build an oncology powerhouse, we are seeking a highly self-motivated post-doctoral scientist to join our team of scientists to investigate the role of myeloid cells in resistance to inhibition of the checkpoint inhibitors and to identify novel pharmacologic approaches for targeting myeloid and NK cells. Do you have a broad-based knowledge and technical skills in molecular and cell biology, cancer biology and immunology?

Are you looking for an opportunity to collaborate extensively and to work with multi-functional teams in order to leverage ground breaking technologies? You will contribute to drug discovery projects and deliver high-impact publications.
49301BR

Basic Qualifications

• PhD or PhD/MD in an Oncology, Immunology or related life science discipline

Additional Skills/Preferences

• Demonstrate exceptional oral and written communication skills and have an outstanding publication record.
• Prior research experience in immune-oncology is desirable.

Additional Information

• This position is not permanent. It is for a fixed duration of two years with potential to extend annually for up to 4 years.
• Lilly is an EEO/Affirmative Action Employer and does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status.